EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone Derivatives

Sandeep Bindra, Won Kyeong Jeong, Muzammil Kabier, Sunil Kumar, Sachithra Thazhathuveedu Sudevan, Harish Chandra Vishwakarma, Della Grace Thomas Parambi, Naseer Maliyakkal, Sandeep Kumar, Leena K Pappachen, Hoon Kim, Bijo Mathew

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71405 ↗

At a glance

Journal article in Chemistry & Biodiversity, 2026. Written by Sandeep Bindra and 11 co-authors. Institution: Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, India. Major MEDLINE topics: Thiosemicarbazones, Monoamine Oxidase Inhibitors, Semicarbazones, Monoamine Oxidase. Cited 1 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Deanship of Research and Graduate Studies at King Khalid University, National Research Foundation of Korea (NRF), Korean Government.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Twenty semicarbazone and thiosemicarbazone derivatives ( T1–T20 ) were synthesized and evaluated for their inhibition of monoamine oxidases and cholinesterases. Most compounds showed stronger inhibition of MAO‐B than MAO‐A. Among the synthesized compounds, T6 most strongly inhibited MAO‐B (IC 50 = 6.45 µM), followed by T17 (IC 50 = 9.46 µM). T6 and T17 exhibited the highest selectivity index values (3.60 and >4.23, respectively) for MAO‐B as compared with MAO‐A. T6 was a competitive MAO‐B inhibitor. Regarding structure–activity relationship, the thiosemicarbazone T1 (IC 50 = 20.74 µM) showed >1.93 times better MAO‐B inhibition than the semicarbazone T5 (IC 50 >40 µM); a similar pattern was observed for T6 vs. T10 , T11 vs. T15 , and T16 vs. T20 , indicating that the thiosemicarbazone derivatives exhibited better MAO‐B inhibition than the semicarbazone derivatives when the terminal –NH 2 group was free. All the compounds showed less than 50% inhibition of acetylcholinesterase at 10 µM. Comparatively, compounds T3 and T12 exhibited 70.65 and 61.94% inhibition of butyrylcholinesterase at 10 µM, respectively. Docking studies of the MAO‐B inhibition of the most promising molecules were performed using MzDOCK. Collectively, thiosemicarbazone derivatives, specially T6 and T17 , warrant further investigation as the promising candidates for the development of novel therapeutics targeting MAO‐B‐related disorders.

Subjects

MeSH terms (MEDLINE)

ThiosemicarbazonesMonoamine Oxidase InhibitorsSemicarbazonesMonoamine OxidaseCholinesterase InhibitorsStructure-Activity RelationshipButyrylcholinesteraseHumansAcetylcholinesteraseMolecular Docking SimulationMolecular StructureAnimalsDose-Response Relationship, Drug

Author keywords

MzDOCKbutyrylcholinesterasemonoamine oxidase‐Bsemicarbazonesstructure–activity relationshipsthiosemicarbazones

Substances

ThiosemicarbazonesMonoamine Oxidase InhibitorsSemicarbazonesMonoamine OxidaseCholinesterase InhibitorsButyrylcholinesteraseAcetylcholinesterase

Authors and institutions

  • Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, India.
  • Department of Pharmacy, College of Pharmacy, Sunchon National University, Suncheon, South Korea.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia.
  • Department of Basic Medical Sciences, College of Applied Medical Sciences, King Khalid University, Khamis Mushait, Saudi Arabia.
  • School of Pharmacy & DST-FIST, Sharda University, Greater Noida, Uttar Pradesh, India.

Funding

  • Deanship of Research and Graduate Studies at King Khalid University
  • National Research Foundation of Korea (NRF)
  • Korean Government

Cite

APA

Bindra, S., Jeong, W. K., Kabier, M., Kumar, S., Sudevan, S. T., Vishwakarma, H. C., Parambi, D. G. T., Maliyakkal, N., Kumar, S., Pappachen, L. K., Kim, H., & Mathew, B. (2026). Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone Derivatives. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71405

Vancouver

Bindra S, Jeong WK, Kabier M, Kumar S, Sudevan ST, Vishwakarma HC, et al. Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone Derivatives. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71405

BibTeX
@article{Bindra2026,
  author = {Bindra, Sandeep and Jeong, Won Kyeong and Kabier, Muzammil and Kumar, Sunil and Sudevan, Sachithra Thazhathuveedu and Vishwakarma, Harish Chandra and Parambi, Della Grace Thomas and Maliyakkal, Naseer and Kumar, Sandeep and Pappachen, Leena K and Kim, Hoon and Mathew, Bijo},
  title = {Monoamine Oxidase and Cholinesterase Inhibition Profiles of Semicarbazone and Thiosemicarbazone Derivatives},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71405}
}
Start for free →